Skip to Content

N 739 150 (Mexiletine Hydrochloride 150 mg)

Pill with imprint N 739 150 is Tan / Orange, Capsule-shape and has been identified as Mexiletine Hydrochloride 150 mg. It is supplied by Teva Pharmaceuticals USA.

Mexiletine is used in the treatment of ventricular tachycardia; arrhythmia and belongs to the drug class group I antiarrhythmics. Risk cannot be ruled out during pregnancy. Mexiletine 150 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for N 739 150

Mexiletine hydrochloride 150 mg N 739 150
Mexiletine hydrochloride 150 mg N 739 150
Mexiletine hydrochloride 150 mg N 739 150
Mexiletine hydrochloride 150 mg N 739 150 Front
Mexiletine hydrochloride 150 mg N 739 150 Back

Mexiletine Hydrochloride

Imprint
N 739 150
Strength
150 mg
Color
Tan / Orange
Size
18.00 mm
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Group I antiarrhythmics
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Teva Pharmaceuticals USA
Inactive Ingredients
silicon dioxide, magnesium stearate, corn starch, FD&C Yellow No. 6, gelatin, titanium dioxide, D&C Red No. 28, FD&C Blue No. 1, ammonia, ferrosoferric oxide, D&C Yellow No. 10, alcohol, FD&C Blue No. 2, FD&C Red No. 40, isopropyl alcohol, butyl alcohol, propylene glycol, shellac

Note: Inactive ingredients may vary.

Labelers / Repackagers

NDC CodeLabeler / Repackager
00093-8739 Teva Pharmaceuticals USA, Inc.
42291-0624 AvKare, Inc.
49999-0916 Lake Erie Medical and Surgical Supply (repackager)

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.